Related Experiment Videos
Complement receptor type 1 (CD35) mediates inhibitory signals in human B lymphocytes
Mihály Józsi1, József Prechl, Zsuzsa Bajtay
1Department of Immunology and Research Group of the Hungarian Academy of Sciences, Eötvös Loránd University, Budapest, Hungary.
Journal of Immunology (Baltimore, Md. : 1950)
|March 9, 2002
Summary
Complement receptor type 1 (CR1) negatively regulates human B cell activation. CR1 clustering inhibits B cell proliferation and signaling, revealing a key role in immune response modulation.
Area of Science:
- Immunology
- Cell Biology
Background:
- The complement system, particularly C3, links innate and adaptive immunity.
- The CR2/CD19/CD81 complex promotes B cell activation via B cell antigen receptor (BCR) co-ligation.
- Complement receptor type 1 (CR1) is another C3 receptor on B cells with an unclear function.
Purpose of the Study:
- To investigate the role of human CR1 in B cell activation.
- To elucidate the functional consequences of CR1 engagement on B lymphocytes.
Main Methods:
- Using aggregated C3 and C3(H2O) as ligands for CR1.
- Studying the effects of CR1 clustering on human tonsil B cell proliferation.
- Analyzing intracellular calcium (Ca2+) levels and protein phosphorylation in response to BCR stimulation.
Main Results:
- CR1 ligand binding inhibited B cell proliferation induced by suboptimal anti-IgM.
- This inhibitory effect persisted even with co-stimulatory cytokines (IL-2, IL-15).
- CR1 engagement reduced BCR-induced intracellular Ca2+ flux and cytoplasmic protein phosphorylation.
Conclusions:
- Human CR1 plays a negative regulatory role in BCR-mediated B cell activation.
- CR1 clustering dampens key signaling pathways essential for B cell activation.
- These findings highlight CR1 as a modulator of B cell immune responses.